nifekalant hydrochloride has been researched along with Cardiomyopathies, Primary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hotoda, K; Kokaji, K; Kumamaru, H; Okamoto, M | 1 |
1 other study(ies) available for nifekalant hydrochloride and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Experience with nifekalant hydrochloride in a patient with ischemic cardiomyopathy and severe ventricular dysfunction after dor operation.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiomyopathies; Electric Countershock; Humans; Male; Middle Aged; Myocardial Ischemia; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |